"10.1371_journal.pone.0014626","plos one","2011-02-15T00:00:00Z","James S Cavenaugh; Dorka Awi; Maimuna Mendy; Adrian V S Hill; Hilton Whittle; Samuel J McConkey","Medical Research Council Laboratories, Banjul, The Gambia; Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, United Kingdom; David H. Smith Center for Vaccine Biology and Immunology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, United States of America; Institute of Maternal and Child Health, University of Port Harcourt, Post Harcourt, Nigeria; International Agency for Research on Cancer, Lyon, France; The Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom; Department of International Health and Tropical Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland","Conceived and designed the experiments: JSC MM AVH HCW SJM. Performed the experiments: JSC DA MM SJM. Analyzed the data: JSC MM SJM. Wrote the paper: JSC DA MM AVH HCW SJM. Responsible for drafting the manuscript and for most of the immunology data: JSC. Wrote significant portions of the manuscript and was responsible for the clinical data: DA. Assisted in the revisions of the manuscript and responsible for the serological and virological data: MM. Contributed to the design of the study, the selection of antigens and the delivery system, and reviewed the paper: AVSH. Provided helpful ideas for the strategic direction of the study and critiques of the manuscript: HW. Was the principal investigator who wrote the grant, and designed and supervised all aspects of the project: SM.","Samuel J. McConkey has performed consultancy work for Oxxon Therapeutics in 2000 and 2001. Adrian V. S. Hill was a founding scientist of Oxxon Therapeutics. No other relevant competing interests are known to the authors. The conflicts of interest described above did not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","02","James S Cavenaugh","JSC",6,TRUE,5,4,3,6,TRUE,TRUE,FALSE,0,NA,FALSE
